Click here for more information and to complete a survey on the Michigan BioTrust for Health
The process of making newborn screening results available through MCIR to authorized providers has begun.
Most newborn screening results will be available approximately two weeks after birth.
Notice of Newborn Screening
Advisory Committee Meetings for 2009
The Newborn Screening Advisory Committee Meetings are tentatively scheduled from 1:00pm to 4:00pm on the third Wednesday of the months of April (4/15), August (8/19), December (12/16). For more information e-mail
mdch-newbornscreening@michigan.gov
The next meeting is scheduled August 19, 2009
Hosted by Children's Hospital of Michigan
Detroit, Michigan
State law
requires that all Michigan infants are screened for a variety of disorders at 24 to 36 hours of age. An
amendment
to this law was signed by Governor Granholm in February, 2006. The Newborn Screening Program is conducted jointly with the Bureau of Laboratories. Program efforts assure that: 1) all Michigan infants receive newborn screening; 2) follow-up for infants with positive screening tests have access to treatment and a medical home, and 3) provides long-term follow-up and monitoring of health outcomes.
Four
Medical Management Centers
provide diagnostic confirmation and treatment for affected children. The four centers are: Children's Hospital of Michigan Metabolic Clinic (CHMMC); Endocrine Follow-up Program (EFUP) at the University of Michigan; and, the Sickle Cell Disease Association of America (SCDAA), Michigan Chapter; Newborn Screening and Coordinating Program for Cystic Fibrosis at the University of Michigan.
All infants born in Michigan are screened for fifty disorders. Click for a
printable list of the disorders included
in the newborn screening panel.
Amino Acid Disorders: *
Phenylketonuria
(PKU) or Benign hyperphenylalaninemia or Biopterin cofactor biosysnthesis or Defects of biopterin cofactor regeneration (PKU/H-PHE/BIOPT(BS)/BIOPT(Reg)),
*
Maple Syrup Urine Disease
(MSUD),
*
Homocystinuria
(HCY) or Hypermethioninemia (HCY/MET), *Citrullinemia or Citrullinemia Type II or
*
Citrullinemia and Argininosuccinic Acid
(
ASA) Tyrosinemia Type I (TYR I), Argininemia (ARG)
Fatty Acid Oxidation Disorders: Carnitine:acylcarnitine translocase deficiency or Carnitine palmitoyltransferase II deficiency(CACT/CPT II), Carnitine uptake defect (CUD), Carnitine palmitoyltransferase IA deficiency (liver) (CPT 1A), Short-chain acyl-CoA dehydrogenase deficiency (SCAD), Glutaric acidemia type II (GA II), *
Medium Chain Acyl-CoA Dehydrogenase Deficiency
(MCAD), Long-chain L-3-OH acyl-CoA dehydrogenase deficiency or Trifunctional protein deficiency (LCHAD/TFP), Very long-chain acyl-CoA dehydrogenase deficiency (VLCAD), Medium-chain ketoacyl-CoA thiolase deficiency (MCKAT), Medium/short-chain L-3-OH acyl-CoA dehydrogenase deficiency (M/SCHAD), Dienoyl-CoA reductase deficiency (DE RED)
Organic Acid Disorders: Isovaleric acidemia or 2-Methyl butyryl-CoA dehydrogenase deficiency (IVA/2MBG), 3-Methylcrotonyl-CoA carboxylase deficiency (3MCC), 3-OH 3-CH3 glutaric aciduria or 3-Methylglutaconic aciduria (HMG/3MGA), Beta-ketothiolase deficiency (BKT), Glutaric acidemia type I (GA I), Propionic acidemia or Methylmalonic acidemia (mutase deficiency) or Methylmalonic acidemia (Cbl A,B) or Methylmalonic acidemia (Cbl C,D) (PA/MUT/Cbl A,B/Cbl C,D), Multiple carboxylase deficiency (MCD), 2-Methyl 3 hydroxy butyric aciduria (2M3HBA), Malonic acidemia (MAL), Isobutyryl-CoA dehydrogenase deficiency (IBG)
Endocrine Disorders: *
Congenital Adrenal Hyperplasia
(CAH),
*
Congenital Hypothyroidism
(CH)
Other
Disorders:
*
Galactosemia
(GALT),
*
Biotinidase Deficiency
(BIOT),
*
Cystic Fibrosis
(CF)
Hemoglobinopathies:
*
Sickle cell anemia
(Hb SS), Hb S/C Disease (Hb S/C), Hb S/Beta-thalassemia, (Hb S/Beta-Th), Variant Hb-pathies (Var Hb)
Hearing:
Early Hearing Detection and Intervention (EHDI) Program
|
NEWBORN SCREENING UPDATES
|
|
·
NBS 2009 Spring Update
·
NBS 2008 Fall Update
·
NBS 2008 Summer Update
·
NBS 2007 Fall Update
·
NBS 2007 Spring Update
·
NBS 2007 Winter Update
·
NBS 2006 October Update
·
NBS 2006 July Update
·
NBS 2006 April Update
·
NBS 2006 January Update
·
NBS 2005 October Update
·
NBS 2005 July Update
·
NBS 2005 April Update
·
NBS 2005 January Update
|
|
NEWBORN SCREENING REPORTS
|
|
·
NBS 2007 Report
·
NBS 2006 Report
·
NBS 2004 Report
|
|
IMPORTANT INFORMATION FOR PROFESSIONALS
|
|
Revised NICU guidelines for infants weighing less than 1800 grams went into effect March 1, 2007. The following references are now available to download and/or print
NICU Fact Sheet
,
Practitioners Manual 2007
,
NBS NICU algorithm
.
|
|
The Newborn Screening (NBS) laboratory began Saturday testing on June 21, 2008.
These and other expanded services were required as part of recommendations by the MDCH Newborn Screening Quality Assurance committee that went into effect March 2007. (Note: Senate Bill 794 amended the 1978 Public Act 368 by adding sections 5430 and 5432).
To view complete announcement letter:
Saturday Testing
|
|
The Region 4 Genetics Collaborative announces the availability of
Newborn Screening: What Prenatal Caregivers Need to Know
. This self-paced, on-line educational module is accessible free of charge to all health care professionals and providers involved in the care of new and expectant mothers. Free CEUs are also available.
|
|
Effective February 1, 2006, nurse participants who complete the entire
Newborn Screening Educational Online Tutorial
, submit the posttest, evaluation, and required demographic information will be eligible to receive a certificate for 1.2 contact hours. This continuing nursing education activity was approved by the Michigan Nurses Association, an accredited approver of nursing continuing education by the American Nurses Association.
Contact
mdch-newbornscreening@michigan.gov
for information. Feel free to download and/or print the
Newborn Screening Education Flyer
.
|
|
Feel free to download or copy the documents and/or information listed below for use by your facility/agency. Please identify the Michigan NBS Program Webpage as your source of information.
NOTICE: The Newborn Screening Program brochure,
A First Step to Your Baby's Health
, is now available in
Spanish
and
Arabic
. To order, contact Val Klasko, 517-241-5583 or
KLASKO@michigan.gov
.
Feel free to download and use the
Genomics Resource Order Form
to review and order NBS and other program brochures.
Encourage your staff to review the
Instructions for completing the Newborn Screening card
in an effort to reduce the number of NBS cards that are incomplete when received in the state NBS laboratory.
Encourage your staff to use the
Weight Conversion Chart
to convert pounds and ounces to grams.
Encourage your staff to use the
Military Time Chart
to convert hours to the 24 hour clock.
Be sure to include the
Newborn Screening card replacement form
when sending the blue NBS cards in for replacement to the address noted on the form.
Automatic Fax Reporting of NBS Results
The
Newborn Screening Disorders Table
contains additional information on twelve of the disorders that are included in the NBS screening panel.
If a parent requests
Supplemental Newborn Screening Information
remember that the NBS specimen must still be obtained and submitted on the state NBS card.
The Congenital Hypothyroidism screening program
Interpretation of the Newborn Hemoglobin Screening Process
NBS card
fee adjustment
effective October 1st
Newborn Screening Online Tutorial Flyer
Nursing contact hours are now available!
The
Newborn Screening Specimen Collection Presentation
contains information on the proper method to obtain the NBS specimen.
The
Newborn Screening Program Presentation
contains information on the NBS program and the proper method to obtain the NBS specimen.
|
|
IMPORTANT INFORMATION FOR
PARENTS AND FAMILIES
|
|
A First Step to Your Baby's Health
, is a free brochure available from the Newborn Screening Program. This brochure contains information on the Newborn Screening Program, frequently asked questions, a list of the disorders screened, and contact information.
NOTE: This brochure is also available in
Arabic
and
Spanish
.
|
|
The NBS laboratory routinely saves all newborn screening samples after testing is completed, unless otherwise directed by a parent or legal guardian. In accordance with state law, some leftover de-identified samples may be used for medical research after all directly identifying information (name, address, etc.) is removed. However, the NBS laboratory always keeps one complete "blood spot" in case it is ever needed by the child or family.
Parents who wish to have their infant's leftover sample stored by the laboratory, but not made available for possible future medical research, should fill out the
Directive to remove NBS sample from research
form and mail or fax to the laboratory.
Parents who wish to have their infant's newborn screening blood sample destroyed after testing is complete should fill out the
Directive to destroy NBS sample
request form and mail to the laboratory along with required documentation.
For questions please call 1-866-673-9939.
|
|
A Newborn Screening Nurse Consultant is available to answer questions and offer support to families of infants and children who have been diagnosed with any of the NBS disorders. Call the toll free number, 1-866-673-9939, and request a return call.
|
|
The
PKU Resource Website
is maintained by the parent of a child with PKU is a resource for parents of children diagnosed with PKU and other metabolic disorders.
|
|
Your infant or child may be eligible for benefits from the Department of Community Health
Children's Special Health Care Services
Program. Their toll free family phone line is 1-800-359-3722.
|
|
Prior to being discharged home from the hospital, your newborn may have received a hearing screen. The
Early Hearing Detection and Intervention Program
monitors the results of this hearing screen.
|
|
The
Early On Program
is available to provide early intervention services from birth to age three for infants and toddlers with disabilities
|
Links for families:
March of Dimes Newborn Screening Parent information
Contact: William Young, PhD
Phone: 517-335-9205